Vaccine Development News

This is selected news for Vaccine Development, which is filed under Healthcare Topics. There are 1.8K news items for this page. Vaccine Development is occasionally combined with Texas Children's Hospital, Peter Hotez and Bill & Melinda Gates Foundation in news items. A press release filter page is also available for Vaccine Development.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source
12/2/2022 Tonix Pharmaceuticals Presents Development Update on Potential Smallpox and Monkeypox Vaccine TNX-801 in an Oral Presentation at the World Vaccine and Immunotherapy Congress – Marketscreener.com
... that Seth Lederman, M.D., Chief Executive Officer of Tonix Pharmaceuticals, presented data from the Company's TNX-801 (live horsepox virus vaccine) smallpox and monkeypox vaccine development program in an oral presentation at the World Vaccine and Immunotherapy Congress 2022, being held in San Diego, Calif., November 28 ‚Ai December ...
thehoopsnews.com
12/1/2022 Icahn School of Medicine at Mount Sinai Continues Drive to Diversify Research by Appointing New Biomedical Laureates
... With each new biomedical laureate, the Health System brings new eyes and ears to critically important areas of medicine in this case, diabetes research and vaccine development and new opportunities to be truly diverse and inclusive in biomedical research,‚Au says Eric J. Nestler, MD, PhD, Nash Family Professor of ...
newswise.com
12/1/2022 Viral genome sequencing: The key to preventing the next pandemic | Modern Healthcare
... Identification of variants as they emerge and spread across geographic regions can help inform policy and public health decisions, as well as solutions such as vaccine development. But the process of collecting and sequencing samples is not yet universally available across all regions or for all pathogens, which have the ...
Modern Healthcare
12/1/2022 Tonix Pharmaceuticals Presents Development Update on Potential Smallpox and Monkeypox Vaccine TNX-801 in an Oral Presentation at the World Vaccine and Immunotherapy Congress
... that Seth Lederman, M.D., Chief Executive Officer of Tonix Pharmaceuticals, presented data from the Company's TNX-801 (live horsepox virus vaccine) smallpox and monkeypox vaccine development program in an oral presentation at the World Vaccine and Immunotherapy Congress 2022, being held in San Diego, Calif., November 28 - December 1 ...
Yahoo News
12/1/2022 Banking on a Shot in the Dark
... aeroplane while we were still building it. We couldn‚Aot wait for data, we had to do so much at risk.‚Au Pfizer compressed its vaccine development timeline from 10 years to a mere nine months by simultaneously developing and testing the product in human trials - Pfizer and other COVID ...
theburningplatform.com
12/1/2022 Tonix Pharmaceuticals Presents Development Update on
... that Seth Lederman, M.D., Chief Executive Officer of Tonix Pharmaceuticals, presented data from the Company's TNX-801 (live horsepox virus vaccine) smallpox and monkeypox vaccine development program in an oral presentation at the World Vaccine and Immunotherapy Congress 2022, being held in San Diego, Calif., November 28 - December 1 ...
Globe Newswire
12/1/2022 Bioprocess Skills Accelerator Programme 2023 for young South Africans
The Bioprocess Skills Accelerator Programme takes place over 4-months and is designed to equip you with the necessary Biotechnology skills to be able to seamlessly enter the industrial biotechnology job market. This sector includes, vaccine development and production, biological agents and metabolites, pharmaceutical active ingredients as well as other ...
opportunitiesforafricans.com
12/1/2022 Behind the facial treatments | dispatchist.com
... virologist Catherine Gill puts the faces of the researchers behind the names of the pharmaceutical and biotech companies associated with these treatments.By rigorously showcasing candidate vaccine development from the ground up but also by humanizing the process, Catherine Gill wanted Changing the picture of vaccines.For a year, I followed, from ...
dispatchist.com
12/1/2022 ELISpot and FluoroSpot Assay Market Report 2022: Increasing Use of Elispot and Fluorospot Assays in Oncology Fuels Sector
DUBLIN , Dec. 1, 2022 /PRNewswire/ -- The "ELISpot and FluoroSpot Assay Market by Product (Assay Kit (T Cell and B Cell assay), Analyzer, Ancillary Products), Application (Transplants, Vaccine Development), End User (Hospitals & Clinical Labs, Research Institutes) - Global Forecast to 2027" report has been added to ResearchAndMarkets.com's offering. The global ELISpot and ...
PR Newswire
12/1/2022 Cape Innovation & Technology Initiative Bioprocess Skills Accelerator Programme 2023
... and is designed to equip you with the necessary Biotechnology skills to be able to seamlessly enter the industrial biotechnology job market. This sector includes, vaccine development and production, biological agents and metabolites, pharmaceutical active ingredients as well as other sectors generating value from biological sources. The skills developed in ...
opportunitydesk.org
12/1/2022 LymeX Prize Competition Announces Ten Phase 1 Winners
... to introduce ‚Aunew and/or improved‚Au diagnostic detection methods. I concluded that a chronic relapsing seronegative disease does not fit the business model of vaccine development, patent royalties and pharmaceutical profits so laboratory confirmation of persistent infection after antibiotic treatment must be squelched/suppressed at all costs. Examples 1 ...
madisonarealymesupportgroup.com
12/1/2022 More than half of U.S. adults weren’t concerned about the flu season, survey shows
Miracles Start in the Lab: the quest to find a vaccine to cure AIDS Dr. Larry Corey To commemorate World AIDS Day, News Medical spoke to Dr. Larry Corey, an internationally renowned expert in virology, immunology, and vaccine development, and the former president and director of Fred Hutch, about his ...
News Medical Net
12/1/2022 mRNA vaccines offer one-two punch to combat malaria
... deaths every year. Vaccines are one intervention that could help eliminate this deadly disease, yet a highly effective vaccine remains elusive. Recent technological advances in vaccine development‚Aisuch as the mRNA vaccines for SARS-CoV2‚Aicould lead to a new generation of malaria vaccines. Now, a research team led by ...
MedicalXpress
12/1/2022 Chris Whitty warns Britain faces ‘prolonged period’ of excess deaths
... said heart disease and cancer cases were missed in Covid - Comments came in a ‚Aotechnical report‚Ao published on the pandemic challenges - Warned speed of vaccine development could lull UK into false sense security Britain will face a ‚Aoprolonged period‚Ao of deaths due to the pandemic, but not from ...
planetnewspost.com
12/1/2022 Chris Whitty warns Britain faces 'prolonged period' of excess deaths NOT caused by Covid due to collateral effects of lockdown - NewsExplorer
Chief Medical Officer said heart disease and cancer cases were missed in CovidComments came in a 'technical report' published on the pandemic challenges Warned speed of vaccine development could lull UK into false sense security Britain will face a ‚Aoprolonged period‚Ao of deaths due to the pandemic, but not ...
newsexplorer.net
12/1/2022 Chris Whitty warns Britain is heading into an ‘extended period’ of excess deaths
... heart disease and cancer cases were missed in Covid - Comments came in a ‚Autechnical report‚Au published on the pandemic challenges - The cautioned speed of vaccine development could put the UK to sleepalso feel safe Britain will face an ‚Aoextended period‚Ao of deaths from the pandemic, but not from ...
usmail24.com
11/30/2022 Intravacc launches phase I clinical trial of Avacc 10®, an intranasal subunit booster vaccine for SARS-CoV-2
... influenza. Around 40% of childhood disease vaccines are based on Intravacc's know-how and proprietary technology. Intravacc offers a wide range of expertise for independent vaccine development, from concept to Phase I/II clinical studies for partners around the world, including universities, public health organizations (WHO, Bill & Melinda Gates Foundation ...
PR Newswire
11/30/2022 Intravacc launches phase I clinical trial of Avacc 10®, an intranasal subunit booster vaccine for SARS-CoV-2
... influenza. Around 40% of childhood disease vaccines are based on Intravacc's know-how and proprietary technology. Intravacc offers a wide range of expertise for independent vaccine development, from concept to Phase I/II clinical studies for partners around the world, including universities, public health organizations (WHO, Bill & Melinda Gates Foundation ...
Yahoo News
11/30/2022 Our Pediatric 'Immunity Debt' Is Really an 'RSV Debt' | MedPage Today
... among children under 1 year old in the U.S.; a killer of older adults at rates fairly similar to influenza; and a virus for which vaccine development failed decades ago. But regardless of the under-appreciated impact of RSV in the pre-COVID era, many people are questioning what is ...
Medpage Today
11/30/2022 Global Human Vaccines Market Report 2022: Growing Prevalence of Emerging and Re-Emerging Infectious Diseases Fuels Sector - ResearchAndMarkets.com | Business Wire
... a CAGR of 7.48%. Market Dynamics Drivers Growing Prevalence of Emerging and Re-Emerging Infectious Diseases Increasing Focus on Immunization Programs Growing Government Support for Vaccine Development Increasing Industry Initiatives to Enhance Vaccine R&D Restraints High Cost of Vaccine Development Low Purchasing Power in Developing Countries Opportunities High Growth ...
Business Wire
11/30/2022 Global Human Vaccines Market Report 2022: Growing Prevalence of Emerging and Re-Emerging Infectious Diseases Fuels Sector - ResearchAndMarkets.com
... a CAGR of 7.48%. Market Dynamics Drivers Growing Prevalence of Emerging and Re-Emerging Infectious Diseases Increasing Focus on Immunization Programs Growing Government Support for Vaccine Development Increasing Industry Initiatives to Enhance Vaccine R&D Restraints High Cost of Vaccine Development Low Purchasing Power in Developing Countries Opportunities High Growth ...
post-gazette.com
11/30/2022 Miracles start in the lab: the quest to find a vaccine to cure AIDS
Miracles start in the lab: the quest to find a vaccine to cure AIDS Dr. Larry Corey To commemorate World AIDS Day, News Medical spoke to Dr. Larry Corey, an internationally renowned expert in virology, immunology, and vaccine development, and the former president and director of Fred Hutch, about his ...
News Medical Net
11/30/2022 Researchers explore gut microbiome dysbiosis in acute COVID-19 infection and recovery
Miracles Start in the Lab: the quest to find a vaccine to cure AIDS Dr. Larry Corey To commemorate World AIDS Day, News Medical spoke to Dr. Larry Corey, an internationally renowned expert in virology, immunology, and vaccine development, and the former president and director of Fred Hutch, about his ...
News Medical Net
11/30/2022 Global Human Vaccines Market Report 2022: Growing Prevalence of Emerging and Re-Emerging Infectious Diseases Fuels Sector - ResearchAndMarkets.com
... a CAGR of 7.48%. Market Dynamics Drivers Growing Prevalence of Emerging and Re-Emerging Infectious Diseases Increasing Focus on Immunization Programs Growing Government Support for Vaccine Development Increasing Industry Initiatives to Enhance Vaccine R&D Restraints High Cost of Vaccine Development Low Purchasing Power in Developing Countries Opportunities High Growth ...
acrofan.com
11/30/2022 Global Human Vaccines Market Report 2022: Growing Prevalence of Emerging and Re-Emerging Infectious Diseases Fuels Sector - ResearchAndMarkets.com
... a CAGR of 7.48%. Market Dynamics Drivers - Growing Prevalence of Emerging and Re-Emerging Infectious Diseases - Increasing Focus on Immunization Programs - Growing Government Support for Vaccine Development - Increasing Industry Initiatives to Enhance Vaccine R&D Restraints - High Cost of Vaccine Development - Low Purchasing Power in Developing Countries Opportunities - High Growth ...
Business Wire